Tueo Health Oversubscribes Seed Round to Support Clinical Study and Growth

Digital Health Start-Up Helps Manage Pediatric Asthma

SAN FRANCISCO, July 24, 2017Tueo Health, a digital health start-up company that has developed a unique solution for monitoring and managing pediatric asthma, has closed $1.1 million in seed round funding. The seed financing was led by Launchpad Digital Health, with participation from Plug and Play, and other strategic angel investors.

“Asthma is a costly chronic disease that affects more than 7 million children in the US alone,” said Tueo Founder and CEO, Bronwyn Harris, MD.  “Over half of asthma related direct healthcare costs are from hospital-based care that could be avoided by better asthma control.”

According to Harris, poor asthma control not only increases healthcare utilization, but results in missed school days, impaired academic performance, and lower overall quality of life. “Tueo Health empowers families to better manage their child’s asthma,” says Harris.

“New methods of passive monitoring make real control of debilitating conditions possible, and Tueo Health is leading this effort in conditions of the lungs,” said Fred Toney, CEO of Launchpad Digital Health. “With smart inhalers, we can now begin to better measure dosing of drugs, but Tueo provides the critical information necessary on a daily basis to assess how the patient is responding. This valuable data-driven approach will transform the way we treat chronic diseases such as asthma, COPD and others.”

Currently families are tasked with monitoring and managing their child’s health but lack the information and tools they need to do this effectively. To address this need, Tueo Health has created an integrated solution that combines sensor-based nocturnal monitoring; personalized analytics based on physiologic data; a mobile app that delivers data and provides educational and clinical context; and an asthma coach that assists in self-management. Prompts and guidance are based on guidelines from the National Asthma Education and Prevention Program.

“As a parent of a child with asthma, it makes me sad that so many children are limited by the disease,” said Harris, who is both a biomedical engineer and pediatric cardiologist. “At Tueo Health, we believe that families shouldn’t be held hostage by asthma. We are leveraging technological advancements to create the data and tools families need to manage the condition and improve quality of life,” she said.

Tueo will use the new financing to conduct a clinical study starting in September and drive continued application development and market positioning.

The founders of Tueo Health came together as fellows in the Stanford Biodesign Innovation Fellowship, a ten-month program focused on needs-based health technology innovation. The team began looking at this important need in asthma management during the fellowship, starting the early work, including a clinical study at Stanford that has now been translated into the Tueo Health solution.

About Tueo Health

Tueo Health is a San Francisco-based company that is building the first digital health solution to empower families to take better control of asthma management. The first Tueo solution is based on passive nocturnal monitoring, a mobile app, and targeted coaching and education, making it non-invasive and easy to use. Tueo was the Judge’s Choice winner of the Plug and Play Tech Center Summer Summit 2017. More information on Tueo can be found at: www.tueohealth.com.

About Launchpad Digital Health

Launchpad Digital Health is the most active seed stage fund for digital health in the U.S.  Its unique side-by-side immersion program, which outperforms traditional accelerator programs, includes more capital, more time and more intensity for its portfolio companies and their founders.  The founders and senior leadership of Launchpad Digital Health have funded and operated companies throughout the healthcare and technology sectors, including digital health companies, for the past two decades.